17 June 2024

Eden Research Plc

("Eden" or "Company")

Eden Research wins at Small Cap Network Awards

Eden Research plc (AIM: EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technologies for use in the global crop protection, animal health and consumer products industries, is proud to announce that it has been named ESG Company of the Year at the prestigious 2024 Small Cap Network Awards in recognition commitment to environmental, social and governance matters and contribution to the green economy.

As a company focused on innovative solutions to drive sustainable agriculture, ESG is entrenched in all aspects of Eden Research's business strategy. Its plant-derived crop protection products serve as a natural alternative to conventional products which contain harsh, synthetic chemicals that persist and bio-accumulate in the natural environment, causing harm to wildlife, biodiversity, and human health. Eden's products allow farmers to increase crop yield with minimal impact on the environment, allowing the agricultural industry to operate with higher efficiency and address record levels of demand as the population continues to grow.

This award is a reflection of its status as a business with sustainability at its core, as also demonstrated by its recognition by the London Stock Exchange as a contributor to London's green economy through the Green Economy Mark.

Sean Smith, Chief Executive Officer of Eden Research, commented:

"This accolade demonstrates our dedication to creating sustainable solutions that benefit not only our stakeholders but also contribute to the progression of sustainable agriculture and farming practices. This achievement is a reflection of the hard work and commitment of our entire team, partners and investors as we continue to make progress on our business objectives and bring our solutions to market."

For further information contact:

Notes to Editors:

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden's products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides. Eden has three products currently on the market:

Based on plant-derived active ingredients, Mevalone® is a foliar biofungicide which initially targets a key disease affecting grapes and other high-value fruit and vegetable crops.  It is a useful tool in crop defence programmes and is aligned with the requirements of integrated pest management programmes. It is approved for sale in a number of key countries whilst Eden and its partners pursue regulatory clearance in new territories thereby growing Eden's addressable market globally.

Cedroz™ is a bionematicide that targets free living nematodes which are parasitic worms that affect a wide range of high-value fruit and vegetable crops globally.  Cedroz is registered for sale on two continents and Eden's commercial collaborator, Eastman Chemical, is pursuing registration and commercialisation of this important new product in numerous countries globally.

Eden's seed treatment product, Ecovelex was developed to safely tackle crop destruction caused by birds - a major cause of losses in maize and other crops. Ecovelex works by creating an unpleasant taste or odour that repels birds, leaving the seeds safely intact and the birds unaffected and free to find alternative food sources. The product is based on Eden's plant-derived chemistry, registered in the EU, U.S. and elsewhere, and formulated using Eden's Sustaine® microencapsulation system.

Eden's Sustaine^® encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease-of-use. Sustaine microcapsules are naturally-derived, plastic-free, biodegradable micro-spheres derived from yeast. It is one of the only viable, proven and immediately registerable solutions to the microplastics problem in formulations requiring encapsulation.

Eden was admitted to trading on AIM on 11 May 2012 and trades under the symbol EDEN. It was awarded the London Stock Exchange Green Economy Mark in January 2021, which recognises London-listed companies that derive over 50% of their total annual revenue from products and services that contribute to the global green economy. Eden derives 100% of its total annual revenues from sustainable products and services.

For more information about Eden, please visit:  www.edenresearch.com.